These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36193316)

  • 1. Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma.
    Zhang L; Zhang Q; Huang Z; Zhu M; Wang T; Zhu W; Wang X; Zhou X
    Biomed Res Int; 2022; 2022():2053719. PubMed ID: 36193316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
    Meijing Z; Tianhang L; Biao Y
    Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival.
    Yang J; Wu Z; Wu X; Chen S; Xia X; Zeng J
    Front Oncol; 2022; 12():1050288. PubMed ID: 36620557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z; Su M; Li X; Xie J; Han F; Yao J
    BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A signature based on m6A pattern and tumor microenvironment infiltration in clear cell renal cell carcinoma.
    Yang C; Yu T; Li Q; Xie F; Lin Q
    Am J Transl Res; 2022; 14(7):4931-4947. PubMed ID: 35958449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N
    Li C; Zhu M; Gao C; Lu F; Chen H; Liu J; Zhong W
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):33. PubMed ID: 38287827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
    Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
    Front Immunol; 2022; 13():976107. PubMed ID: 36091006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development a m
    Shi G; Li Y; Gao H; Wei Y; Wang Y
    Aging (Albany NY); 2023 Mar; 15(6):1944-1963. PubMed ID: 37019148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
    Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
    Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of m6A modification patterns and development of m6A-hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer.
    Shen X; Zhong J; He J; Han J; Chen N
    Front Immunol; 2022; 13():978092. PubMed ID: 36105819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response.
    Wang XX; Wu LH; Dou QY; Ai L; Lu Y; Deng SZ; Liu QQ; Ji H; Zhang HM
    Front Mol Biosci; 2022; 9():1034928. PubMed ID: 36339715
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
    Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
    Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer.
    Peng B; Lin Y; Yi G; Lin M; Xiao Y; Qiu Y; Yao W; Zhou X; Liu Z
    Sci Rep; 2024 Jul; 14(1):16404. PubMed ID: 39013954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma.
    Ji J; Liu S; Liang Y; Zheng G
    BMC Genom Data; 2023 Aug; 24(1):44. PubMed ID: 37568073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.
    Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y
    Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine (m6A) regulator expression pattern correlates with the immune landscape in lung adenocarcinoma.
    Wan RJ; Bai L; Jiang J; Hu CP; Chen Q; Zhao BR; Zhang Y; Li YY
    Gene; 2022 Aug; 836():146639. PubMed ID: 35700805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.